Pfizer CEO Albert Bourla is still touting the vaccine’s 95.6% efficacy.

Credit: Rumble

Duration: 00:55s 07 Mar 2022 0 shares 2 views

Pfizer CEO Albert Bourla is still touting the vaccine’s 95.6% efficacy.

Pfizer CEO Albert Bourla is still touting the vaccine’s 95.6% efficacy.

You might like

Related news coverage

Pfizer CEO Albert Bourla calls people who spread "vaccine" misinformation - CRIMINALS

Pfizer CEO Albert Bourla calls people who spread "vaccine" misinformation - CRIMINALS

Rumble 30 Mar 2022

Albert Bourla CEO of Pfizer, on why mRNA vaccine was counterintuitive

Albert Bourla CEO of Pfizer, on why mRNA vaccine was counterintuitive

Rumble

17 Mar 2022

Dr. McCullough Goes Straight at Pfizer CEO for Pushing More Jabs Instead of Looking at Safety

Dr. McCullough Goes Straight at Pfizer CEO for Pushing More Jabs Instead of Looking at Safety

Rumble

17 Mar 2022

Pfizer CEO Pushes Fourth Booster – Admits Doesn’t Stop Infections

Pfizer CEO Pushes Fourth Booster – Admits Doesn’t Stop Infections

Rumble

14 Mar 2022

Albert Bourla CEO of Pfizer On Why mNRA Vaccine Was Counterintuitive.

Albert Bourla CEO of Pfizer On Why mNRA Vaccine Was Counterintuitive.

Rumble

13 Mar 2022

Advertisement